Claro Perú

Claro Perú

https://www.claro.com.pe/institucional/sobre-nosotros/
https://www.linkedin.com/company/claroperu/

Claro Perú, a privately owned telecommunications company founded in 2005, operates primarily in Peru. It is a subsidiary of Claro and América Móvil, employing approximately 5,390 people. Its core business is the provision of pay television services.

Revenue

Founded

2005

Headcount

5,385

Headquarters

Peru

Primary Segment

Pay TV services

Ownership

Privately Owned

News Summary:

The provided text contains news stories unrelated to Claro Perú. Therefore, a summary cannot be provided.

Similar Companies

Subscribe for full access to Claro Perú's profile

Claro Perú offers 3 products in the media and telecoms services industry. Claro Perú's product portfolio comprises of pay TV services, telecoms and streaming services.

Subscribe for full access to Claro Perú's products in full detail

Subscribe for full access to Claro Perú's revenue in full detail

Mar

11th

2025

07:27

Financial Results, Caretta Research_Monitor Company

Radiotherapy Market Set to Witness Significant Growth by 2025-2032: Optivus Proton Therapy, Inc., RefleXion, MacroMedics

Radiotherapy Market Share 2025 Radiotherapy Market is estimated to be valued at USD 8.55 Bn in 2025 and is expected to reach USD 14.01 Bn by 2032, exhibiting a CAGR of 7.3% from 2025 to 2032.

Mar

7th

2025

16:16

Management Changes, Caretta Research_Monitor Company

RefleXion Welcomes Two New Management Team Members

RefleXion Medical has appointed Steve Schoch as chief financial officer (CFO) and promoted Phil Aulson to chief operating officer (COO). Both report to President/CEO Todd Powell. “Steve’s 30-year track record of excellence and diverse background will be a tremendous asset to the RefleXion team,” Powell said.

Medical Product Outsourcing

Feb

26th

2025

06:08

Caretta Research_Monitor Company

RefleXion Expands Access to SCINTIX Therapy with First Freestanding Cancer Center

At BHCC, we are committed to advancing cancer care by integrating the latest innovations, ensuring our patients receive the highest quality, cutting-edge treatments,” said Arash (Ari) Gabayan, M.D., Chief of Radiation Oncology and Imaging at Beverly Hills Cancer Center.

Feb

19th

2025

16:40

Management Changes, Caretta Research_Monitor Company

RefleXion Announces Executive Appointments

HAYWARD, Calif.--(BUSINESS WIRE)--Feb 19, 2025-- RefleXion Medical, a theranostic oncology company, today announced the appointment of Steve Schoch as chief financial officer (CFO) and the promotion of Phil Aulson to chief operating officer (COO). Both report to Todd Powell, RefleXion’s president and chief executive officer.

Feb

19th

2025

09:31

Management Changes, Caretta Research_Monitor Company

RefleXion Announces Executive Appointments

HAYWARD, Calif.--( BUSINESS WIRE )-- RefleXion Medical , a theranostic oncology company, today announced the appointment of Steve Schoch as chief financial officer (CFO) and the promotion of Phil Aulson to chief operating officer (COO). Both report to Todd Powell, RefleXion’s president and chief executive officer.

Feb

18th

2025

18:30

Management Changes, Caretta Research_Monitor Company

RefleXion Announces Executive Appointments

HAYWARD, Calif., Feb. 19, 2025 – RefleXion Medical, a theranostic oncology company, today announced the appointment of Steve Schoch as chief financial officer (CFO) and the promotion of Phil Aulson to chief operating officer (COO). Both report to Todd Powell, RefleXion’s president and chief executive officer.

Feb

18th

2025

18:30

Management Changes, Caretta Research_Monitor Company

RefleXion Announces Executive Appointments

HAYWARD, Calif.--( BUSINESS WIRE )-- RefleXion Medical , a theranostic oncology company, today announced the appointment of Steve Schoch as chief financial officer (CFO) and the promotion of Phil Aulson to chief operating officer (COO). Both report to Todd Powell, RefleXion’s president and chief executive officer.

FirstWord Pharma

Feb

12th

2025

23:30

Business Expansion, New Offerings, Caretta Research_Monitor Company

RefleXion expands SCINTIX radiotherapy with first freestanding cancer center install

SCINTIX therapy uses biological signals from a patient’s tumor to guide radiation treatment in real time. It is currently indicated for FDG-guided treatment of lung and bone tumors and is under investigation for additional cancer types.

Feb

12th

2025

13:42

Financial Results, Caretta Research_Monitor Company

Claro Peru Q4 revenue rises over 4%, driven by wireless business

Claro Peru said revenue reached PEN 1.68 billion in the fourth quarter of 2024, up 4.5 percent from a year earlier, driven principally by wireless activities. Service revenue was PEN 1.32 billion, up 5.7 percent and EBITDA rose 7.3 percent to PEN 643 million.

Feb

10th

2025

16:42

Business Expansion, Awards and Recognitions, Caretta Research_Monitor Company

RefleXion Expands Access to SCINTIX Therapy with First Freestanding Cancer Center

Beverly Hills Cancer Center is recognized as a leading private cancer diagnostic and treatment facility in Southern California and beyond. HAYWARD, Calif.--(BUSINESS WIRE)--Feb 10, 2025-- RefleXion Medical , a theranostic oncology company, today announced the scheduled installation of its RefleXion ® X1 platform with SCINTIX ® biology-guided radiotherapy at Beverly Hills Cancer Center (BHCC), the first freestanding cancer center (FSCC) that has installed the RefleXion X1.

The Bakersfield Californian

Feb

10th

2025

16:15

Business Expansion, New Offerings, Caretta Research_Monitor Company

RefleXion Expands Access to SCINTIX Therapy with First Freestanding Cancer Center

HAYWARD, Calif.--(BUSINESS WIRE)--Feb 10, 2025-- RefleXion Medical, a theranostic oncology company, today announced the scheduled installation of its RefleXion ® X1 platform with SCINTIX ® biology-guided radiotherapy at Beverly Hills Cancer Center (BHCC), the first freestanding cancer center (FSCC) that has installed the RefleXion X1.

Feb

10th

2025

15:58

Business Expansion, New Offerings, Caretta Research_Monitor Company

RefleXion Expands Access to SCINTIX Therapy with First Freestanding Cancer Center

HAYWARD, Calif.--(BUSINESS WIRE)--Feb 10, 2025-- RefleXion Medical, a theranostic oncology company, today announced the scheduled installation of its RefleXion ® X1 platform with SCINTIX ® biology-guided radiotherapy at Beverly Hills Cancer Center (BHCC), the first freestanding cancer center (FSCC) that has installed the RefleXion X1.

Claro Perú currently holds broadcasting rights for sports competitions including soccer | association football.

Example Sports Rights Suppliers

Subscribe for full access to Claro Perú's profile

Analyst insight reports

Going native: production in the cloud

Channel hopping: a hybrid approach to TV distribution

Sports rights trends: How sports drives opportunities for media tech and service providers

AV broadcast: A buyer's world

Subscribe to access all analyst insight reports